Arterial Hypertension in Ukraine: Medical and Social Problems of Pathogenesis

IF 0.5
N. Korylchuk, R. Riabushko, I. Haman, Anatolija Krasnova, N. Dovzhuk
{"title":"Arterial Hypertension in Ukraine: Medical and Social Problems of Pathogenesis","authors":"N. Korylchuk, R. Riabushko, I. Haman, Anatolija Krasnova, N. Dovzhuk","doi":"10.51847/uhbo9d7zip","DOIUrl":null,"url":null,"abstract":"Arterial hypertension is becoming increasingly common among diseases of the cardiovascular system. The work aimed to analyze blood pressure control in patients diagnosed with arterial hypertension. Fifty physicians and 1020 patients (under 56 years of age) participated in the study. Regular use of medications was observed in 92% of the patients, and the systolic blood pressure level was 167 mm Hg. More frequent use of renin-angiotensin system blockers compared with diuretics and calcium antagonists was noted, both in monotherapy and in combination therapy. Target BP was achieved in 66% of cases within three months by therapy with amlodipine and retarded indapamide. The majority of patients adhered to the prescribed therapy (97%). The effectiveness of amlodipine and indapamide therapy was in direct correlation with baseline BP values. Significant factors were smoking (lower efficacy), and gender (higher in women). The degree of BP reduction following combined therapy with amlodipine and indapamide was determined to be directly correlated with the beginning BP level. At the same time, female patients and non-smokers see more pronounced dynamics of BP lowering. Pre-treatment is also a crucial element; statins and renin system blockers greatly lower blood pressure when used together.","PeriodicalId":15062,"journal":{"name":"Journal of Biochemical Technology","volume":"1 1","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biochemical Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51847/uhbo9d7zip","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Arterial hypertension is becoming increasingly common among diseases of the cardiovascular system. The work aimed to analyze blood pressure control in patients diagnosed with arterial hypertension. Fifty physicians and 1020 patients (under 56 years of age) participated in the study. Regular use of medications was observed in 92% of the patients, and the systolic blood pressure level was 167 mm Hg. More frequent use of renin-angiotensin system blockers compared with diuretics and calcium antagonists was noted, both in monotherapy and in combination therapy. Target BP was achieved in 66% of cases within three months by therapy with amlodipine and retarded indapamide. The majority of patients adhered to the prescribed therapy (97%). The effectiveness of amlodipine and indapamide therapy was in direct correlation with baseline BP values. Significant factors were smoking (lower efficacy), and gender (higher in women). The degree of BP reduction following combined therapy with amlodipine and indapamide was determined to be directly correlated with the beginning BP level. At the same time, female patients and non-smokers see more pronounced dynamics of BP lowering. Pre-treatment is also a crucial element; statins and renin system blockers greatly lower blood pressure when used together.
乌克兰动脉高血压:发病机制的医学和社会问题
动脉高血压在心血管系统疾病中越来越常见。这项工作旨在分析被诊断为动脉高血压的患者的血压控制。50名医生和1020名患者(56岁以下)参与了这项研究。92%的患者定期使用药物,收缩压水平为167毫米汞柱。与利尿剂和钙拮抗剂相比,在单药和联合治疗中,肾素-血管紧张素系统阻滞剂的使用频率更高。66%的病例在3个月内通过氨氯地平和迟发性吲达帕胺治疗达到目标血压。大多数患者坚持处方治疗(97%)。氨氯地平和吲达帕胺治疗的有效性与基线血压值直接相关。显著因素为吸烟(低疗效)和性别(女性高疗效)。确定氨氯地平与吲达帕胺联合治疗后的血压降低程度与初始血压水平直接相关。与此同时,女性患者和非吸烟者的血压下降趋势更为明显。预处理也是一个关键因素;他汀类药物和肾素系统阻滞剂一起使用时,可大大降低血压。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Biochemical Technology
Journal of Biochemical Technology BIOCHEMISTRY & MOLECULAR BIOLOGY-
自引率
40.00%
发文量
18
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信